HomeCHM • ASX
add
Chimeric Therapeutics Ltd
Previous close
$0.0020
Day range
$0.0020 - $0.0020
Year range
$0.0010 - $0.0090
Market cap
2.02M AUD
Avg Volume
6.18M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Investing.com
1 hour ago
BofA urges investors to buy these 3 sectors, not the S&P 500 By Investing.com
0.96%
1.04%
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.31M | -52.84% |
Operating expense | 1.94M | -51.41% |
Net income | -5.61M | -292.46% |
Net profit margin | -428.19 | -732.08% |
Earnings per share | — | — |
EBITDA | -391.47K | 60.10% |
Effective tax rate | -0.39% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.50M | -50.60% |
Total assets | 5.93M | -68.25% |
Total liabilities | 8.96M | -29.66% |
Total equity | -3.03M | — |
Shares outstanding | 4.11B | — |
Price to book | ∞ | — |
Return on assets | -26.76% | — |
Return on capital | 52.39% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.61M | -292.46% |
Cash from operations | -1.92M | -46.42% |
Cash from investing | -121.17K | — |
Cash from financing | 414.02K | -81.96% |
Net change in cash | -1.63M | -261.48% |
Free cash flow | -11.35K | 97.43% |
About
Founded
2020
Website
